New Zealand markets open in 29 minutes

Context Therapeutics Inc. (CNTX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.0600-0.0600 (-2.83%)
At close: 04:00PM EDT
2.0200 -0.04 (-1.94%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 35.44M
Enterprise value -10.16M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.78
Enterprise value/revenue N/A
Enterprise value/EBITDA 0.78

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-59.61%
S&P500 52-week change 3-11.93%
52-week high 310.8700
52-week low 31.2700
50-day moving average 31.8013
200-day moving average 32.8571

Share statistics

Avg vol (3-month) 3383.92k
Avg vol (10-day) 3405.37k
Shares outstanding 515.97M
Implied shares outstanding 6N/A
Float 89.17M
% held by insiders 15.74%
% held by institutions 125.51%
Shares short (14 Jun 2022) 4274.81k
Short ratio (14 Jun 2022) 40.52
Short % of float (14 Jun 2022) 41.83%
Short % of shares outstanding (14 Jun 2022) 41.72%
Shares short (prior month 12 May 2022) 444.58k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-25.47%
Return on equity (ttm)-58.77%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
Net income avi to common (ttm)-13M
Diluted EPS (ttm)-1.9300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)45.73M
Total cash per share (mrq)2.86
Total debt (mrq)123.58k
Total debt/equity (mrq)0.27
Current ratio (mrq)29.16
Book value per share (mrq)2.84

Cash flow statement

Operating cash flow (ttm)-10.9M
Levered free cash flow (ttm)-8.69M